Defective necroptosis, due to RIPK3 depletion, increases anti-tumor immunity, as evidenced by an increase in tumor infiltrating CD8+ T cells as well as a reduction in myeloid-derived suppressor cells (MDSCs) and tumor-associated macrophages (TAMs) [79]. The gene discussed is CD8A; the disease is neoplasm.